Improving healthcare quality for vulnerable populations through policy analysis.
Designing policies to incentivize high-quality health care for vulnerable Americans: Evidence from the 340B Drug Pricing Program
This study looks at how the 340B Drug Pricing Program helps hospitals that care for low-income patients by checking if it really improves healthcare access and quality for those who need it most.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10913324 on NIH RePORTER |
What this research studies
This research investigates the effects of the 340B Drug Pricing Program, which aims to provide financial support to hospitals serving low-income patients. By analyzing data on clinical quality and drug outcomes, the project seeks to determine if this program effectively enhances healthcare access and quality for vulnerable groups. The research employs advanced quantitative methods and large administrative datasets to assess both intended benefits and any unintended consequences of the policy. Ultimately, the goal is to inform future healthcare policies that better serve at-risk populations.
Who could benefit from this research
Good fit: Ideal candidates for this research include low-income individuals who rely on healthcare services from hospitals participating in the 340B Drug Pricing Program.
Not a fit: Patients who are not low-income or do not utilize services from 340B hospitals may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved healthcare quality and access for vulnerable patients across the United States.
How similar studies have performed: Previous research has shown that similar policy analyses can lead to significant improvements in healthcare delivery for underserved populations.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Desai, Sunita — New York University School of Medicine
- Study coordinator: Desai, Sunita
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.